Kraig Biocraft Laboratories Increases Monster Silk(TM) Silkworm Yields at the Company's New Laboratory

Increase in Transgenic Silkworm Production Seen as Major Step Toward Commercialization of Monster Silk(TM)


LANSING, Mich., June 27, 2012 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB.PK) (the "Company" or "Kraig") announces that the Company's recently opened private laboratory has significantly increased Kraig's ability to generate its proprietary Monster Silk™ production platform silkworms.

The initial focus of the Company's facility is to assist in the commercialization of Kraig's product, Monster Silk™, by significantly ramping up production of the Company's proprietary transgenic silkworms that produce Monster Silk™, a new recombinant spider silk based fiber with potentially broad applications for consumers and industry in the multi-billion dollar marketplace for textiles and performance polymers.

"Our main goal, for the Company's recently opened laboratory, was to rapidly increase our ability to raise our Monster Silk™ silkworms. In the short time it's been operational, we have effectively quadrupled our ability to produce the transgenic silkworms, which produce Monster Silk™," said Company founder and CEO, Kim Thompson.

"We knew that the increase in our laboratory production would be fundamental to the commercialization of Monster Silk™," continued Thompson. "Now that the new laboratory is working as planed, we are looking to exponentially expand our production of Monster Silk™."

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com) is a fully reporting biotechnology company that has achieved a series of scientific breakthroughs in its work with spider silk gene sequences, with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.



            

Contact Data